Haematologica · 2018 · 62 citations · 15 references
Life SciencesGeneticsPathologyHuman GeneticsMedical GeneticsMolecular PathologyGenetic Disease PathologyGenetic DisordersMutation AnalysisBraf V600 MutationsBraf V600e MutationRosai-dorfman Disease
Rosai-Dorfman Disease (RDD), also known as sinus histiocytosis with massive lymphadenopathy, is a rare, nonmalignant histiocytic proliferation of unknown etiology. According to the new classification, it belongs to the R group of histiocytoses. 1 The clinical course of this disease is quite unpredictable with alternating episodes of worsening and reliving of symptoms. The outcome is usually good, and the disease is often self-limiting. Treatment for RDD is only advised in patients with symptomatic disease or who have a vital organ or system compromised. Common therapeutic modalities include surgery, corticosteroids, interferon, chemotherapy, immunotherapy, and radiotherapy. lthough most individuals with RDD have a benign clinical course, some cases are quite challenging, and optimal target therapeutic agents are missing. ] Apart from node enlargement, he had no other symptoms (fever, weight loss or night sweats). A node biopsy was obtained, and diagnosis of RDD was established.
15
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
David M. Hyman, Igor Puzanov, Vivek Subbiah et al. · New England Journal of Medicine · 2015 · 1.7K citations · Full text
Medicine, Oncology, Pharmacology +12
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms
Eli L. Diamond, Benjamin H. Durham, Julien Haroche et al. · Cancer Discovery · 2015 · 533 citations · Full text
Julien Haroche, Fleur Cohen‐Aubart, Jean‐François Emile et al. · Blood · 2012 · 530 citations